Phase II trial of PRX 302 in patients with moderate to severe benign prostatic hyperplasia

Trial Profile

Phase II trial of PRX 302 in patients with moderate to severe benign prostatic hyperplasia

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 09 Dec 2010

At a glance

  • Drugs Topsalysin (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Therapeutic Use
  • Most Recent Events

    • 09 Dec 2010 According to a Protox Therapeutics media release, results of this trial plus another phase I trial [see 700014352] have been published online in European Urology.
    • 24 Nov 2009 Results presented at 30th World Congress of the Societe Internationale d'Urologie, according to a Protox media release.
    • 29 Apr 2009 Lead site (Can Med Clinical Research Centre) and lead investigator added (Pomerville P) from Protox media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top